Imerys (NK) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
21 Sep, 2026Executive summary
Revenue for the first nine months of 2025 was €2,583 million, down 0.7% like-for-like year-over-year, reflecting a strong start and a softer second half due to a U.S. slowdown and ongoing European weakness.
Adjusted EBITDA for the nine months was €421 million (16.3% margin), nearly flat year-over-year excluding joint ventures; Q3 EBITDA was €140 million (16.9–17% margin).
Net income, Group share, for the nine months reached €110 million, a significant improvement from a €143 million loss last year, mainly due to non-cash charges in 2024.
A comprehensive cost reduction and performance improvement program is being launched to simplify the organization and adjust the industrial footprint, targeting improved profitability from 2026.
Key strategic moves include an agreement to acquire SB Mineração in Brazil, advanced discussions for a minority investment in the EMILI Lithium Project, and partnerships to expand the battery materials portfolio and decarbonize operations.
Financial highlights
Q3 2025 revenue was €827 million, down 1.3% year-over-year at constant scope and exchange rates; nine-month revenue was €2,583 million, down 0.7% like-for-like.
Adjusted EBITDA for the first nine months was €421 million, down 21% year-over-year, mainly due to lower JV contributions, perimeter changes, and FX effects.
Net profit for the period reached €110 million, with current net income from continuing operations at €126 million.
Current operating income for the nine months was €216 million, down 34.6% year-over-year.
FX impact was -€47 million, mainly from USD devaluation.
Outlook and guidance
Full-year 2025 adjusted EBITDA guidance is confirmed at €540–580 million, assuming stable macroeconomic conditions and exchange rates.
No significant market recovery expected in the near term; cost actions are being accelerated.
European volumes expected to improve in Q4, aided by anti-dumping measures on Chinese mineral imports.
U.S. recovery anticipated in the second half of 2026; Europe expected to rebound next year, though the magnitude is uncertain.
Latest events from Imerys
- H1 2026 saw 1.8% revenue and 10% EBITDA growth, margin gains, and strong cash flow.NK
Q2 2026 - Stable results, €0.75 dividend, strategic focus on lithium, cost savings, and strong ESG progress.NK
AGM 2026 - Q1 2026 saw modest growth and margin gains, offset by FX and restructuring impacts.NK
Q1 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 2025 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 2024 - H1 2024 adjusted EBITDA up 11% to €384m, margin 20%, and net income from continuing ops up 25%.NK
H1 2024 - All resolutions passed, with strong 2024 results, higher dividend, and strategic progress.NK
AGM 2025 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 2025 - Solid organic growth, margin expansion, and strong ESG progress despite non-cash net loss.NK
H2 2024